Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Mar 17;10(3):e0120304.
doi: 10.1371/journal.pone.0120304. eCollection 2015.

Crystal and EM structures of human phosphoribosyl pyrophosphate synthase I (PRS1) provide novel insights into the disease-associated mutations

Affiliations

Crystal and EM structures of human phosphoribosyl pyrophosphate synthase I (PRS1) provide novel insights into the disease-associated mutations

Peng Chen et al. PLoS One. .

Abstract

Human PRS1, which is indispensable for the biosynthesis of nucleotides, deoxynucleotides and their derivatives, is associated directly with multiple human diseases because of single base mutation. However, a molecular understanding of the effect of these mutations is hampered by the lack of understanding of its catalytic mechanism. Here, we reconstruct the 3D EM structure of the PRS1 apo state. Together with the native stain EM structures of AMPNPP, AMPNPP and R5P, ADP and the apo states with distinct conformations, we suggest the hexamer is the enzymatically active form. Based on crystal structures, sequence analysis, mutagenesis, enzyme kinetics assays, and MD simulations, we reveal the conserved substrates binding motifs and make further analysis of all pathogenic mutants.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. The weblogos of the conserved residues.
(A-D) The logos highlight the similarities and differences amongst the three PRS classes: class I, II and III. The logos demonstrate the overall conservation of the substrate-bound motifs.
Fig 2
Fig 2. Enzyme assays and 4 mutations located in the β9–10 strands.
(A) Enzyme assays of PRS1 and its mutants. (B) The enzyme assay of the H130A mutant displays no AMP product but produces ADP as its catalytic product. (C) The D183H, A190V, H193Q and H193L mutations are located in the antiparallel super flexible β9–10 strands. Error bars were calculated from the mean values, N = 3.
Fig 3
Fig 3. Structural differences between PRS1 and its mutants.
(A-E) Crystal structure superposition between PRS1 and its mutants. The mutant residue is colored green with the gray Fo-Fc map contoured at 2.5-σ in the image. The antiparallel β2–3 strands and the flexible loop are colored lemon.
Fig 4
Fig 4. MD simulation results of the five mutants and the WT PRS1.
(A) Contact numbers of both Asp65 in WT (black line) and Gln65 in D65N (red line) with the ATP binding motif β2–3. (B) Contact numbers of both Gln133 in WT (black line) and Pro133 in Q133P mutant (red line) with the catalytic flexible loop.(C) Contact numbers between the ATP binding motif β2–3 and the catalytic flexible loop for both the WT (black line) and the E43T mutant (red line). (D) Contact numbers of both Met115 in WT (black line) and Thr115 in M115T mutant (red line) with residues that are involved in the interactions with them in the crystal structures, respectively. (E) RMSF of all residues in both WT (black line) and A87T mutant (red line).
Fig 5
Fig 5. Structures of the PRS1 in different states.
(A) Negative stain EM of PRS1 and its complexes with AMPNPP, AMPNPP and R5P, and ADP. The four 2D averages (with scale bar, 50 Å) were identified through reference-free alignment and the classification of EM images of single particles preserved in the negative stain. (B) Hexamer subunit arrangement according to crystallography symmetry operation. (C) The 3D-EM structure of PRS1 with its hexamer crystal structure docked. The 3 different colors represent the three “head to head” dimmers like displayed in Fig. 1B. The figures shows different views of the PRS1 hexamer (PDB:3S5J), which was docked to the 3D EM structures. Scale bar, 50 Å.
Fig 6
Fig 6. The surface conservation among PRS proteins and the distribution of human PRS1 missense mutations associated with disorders.
(A) Only subunit A is shown for the surface conservation analysis of the PRS proteins. The dashed ovals represent different substrate pockets as indicated. The balls represent the different disorders associated with the residues. (B) The distribution of 16 different PRS1 missense mutations. The brown balls represent the residues distributed at the interfaces. The blue balls represented those near substrates or inhibitor binding pockets. The green balls represent those distributed in the inner parts of N- or C-terminal domains.

Similar articles

Cited by

References

    1. Kamal MA, Christopherson RI (2004) Accumulation of 5-phosphoribosyl-1-pyrophosphate in human CCRF-CEM leukaemia cells treated with antifolates. Int J Biochem Cell Biol 36: 545–551. - PubMed
    1. Fisher DI, Safrany ST, Strike P, McLennan AG, Cartwright JL (2002) Nudix hydrolases that degrade dinucleoside and diphosphoinositol polyphosphates also have 5-phosphoribosyl 1-pyrophosphate (PRPP) pyrophosphatase activity that generates the glycolytic activator ribose 1,5-bisphosphate. J Biol Chem 277: 47313–47317. - PubMed
    1. Kadziola A, Jepsen CH, Johansson E, McGuire J, Larsen S, Hove-Jensen B (2005) Novel class III phosphoribosyl diphosphate synthase: structure and properties of the tetrameric, phosphate-activated, non-allosterically inhibited enzyme from Methanocaldococcus jannaschii. J Mol Biol 354: 815–828. - PubMed
    1. Li S, Lu Y, Peng B, Ding J (2007) Crystal structure of human phosphoribosylpyrophosphate synthetase 1 reveals a novel allosteric site. Biochem J 401: 39–47. - PMC - PubMed
    1. de Brouwer APM, van Bokhoven H, Nabuurs SB, Arts WF, Christodoulou J, Duley J (2010) PRPS1 mutations: four distinct syndromes and potential treatment. American journal of human genetics 86: 506–518. 10.1016/j.ajhg.2010.02.024 - DOI - PMC - PubMed

Publication types

Substances

LinkOut - more resources